Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

about

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

Item

http://www.wikidata.org/entity/Q39459198

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@en

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@nl

type

Item

label

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@en

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@nl

prefLabel

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@en

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@nl

P1476

Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.

@en

P2093

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

Tahlita Cm Zuiverloon

http://www.w3.org/2001/XMLSchema#string

P2860

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen

The first 30 years of p53: growing ever more complex

Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all

p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer.

Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor.

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

Comprehensive molecular characterization of urothelial bladder carcinoma

Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

P304

1167-1178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS-2017-0055

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28745580

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics